1FQ5 - Header Asymmetric Unit

HEADER HYDROLASE/HYDROLASE INHIBITOR 03-SEP-00 1FQ5

TITLE X-RAY STRUCTURE OF A CYCLIC STATINE INHIBITOR PD-129,541 BOUND TO TITLE 2 YEAST PROTEINASE A

CAVEAT 1FQ5 CHIRALITY ERROR AT CA CENTER OF SER 63.

COMPND MOL_ID: 1; COMPND 2 MOLECULE: SACCHAROPEPSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ASPARTATE PROTEASE, PROTEINASE A; COMPND 5 EC: 3.4.23.25

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 4932

KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX

EXPDTA X-RAY DIFFRACTION

AUTHOR N.B.CRONIN,M.O.BADASSO,I.J.TICKLE,T.DREYER,D.J.HOOVER,R.L.ROSATI, AUTHOR 2 C.C.HUMBLET,E.A.LUNNEY,J.B.COOPER

REVDAT 6 14-DEC-16 1FQ5 1 TITLE REVDAT 5 13-JUL-11 1FQ5 1 VERSN REVDAT 4 24-FEB-09 1FQ5 1 VERSN REVDAT 3 01-APR-03 1FQ5 1 JRNL REVDAT 2 15-NOV-00 1FQ5 1 JRNL REVDAT 1 20-SEP-00 1FQ5 0

JRNL AUTH N.B.CRONIN,M.O.BADASSO,I.J TICKLE,T.DREYER,D.J.HOOVER, JRNL AUTH 2 R.L.ROSATI,C.C.HUMBLET,E.A.LUNNEY,J.B.COOPER JRNL TITL X-RAY STRUCTURES OF FIVE RENIN INHIBITORS BOUND TO JRNL TITL 2 SACCHAROPEPSIN: EXPLORATION OF ACTIVE-SITE SPECIFICITY. JRNL REF J.MOL.BIOL. V. 303 745 2000 JRNL REFN ISSN 0022-2836 JRNL PMID 11061973 JRNL DOI 10.1006/JMBI.2000.4181

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.F.AGUILAR,N.B.CRONIN,M.BADASSO,T.DREYER,M.P.NEWMAN, REMARK 1 AUTH 2 J.B.COOPER,D.J.HOOVER,S.P.WOOD,M.S.JOHNSON,T.L.BLUNDELL REMARK 1 TITL THE THREE-DIMENSIONAL STRUCTURE AT 2.4 A RESOLUTION OF REMARK 1 TITL 2 GLYCOSYLATED PROTEINASE A FROM THE LYSOSOME-LIKE VACUOLE OF REMARK 1 TITL 3 SACCHAROMYCES CEREVISIAE REMARK 1 REF J.MOL.BIOL. V. 267 899 1997 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.1996.0880

REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : RESTRAIN REMARK 3 AUTHORS : MOSS,DRIESSEN,HANEEF,HOWLIN,HARRIS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 12.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 17302 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1384 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 17302 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2528 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 137 REMARK 3 SOLVENT ATOMS : 105 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 1FQ5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-SEP-00. REMARK 100 THE RCSB ID CODE IS RCSB011808.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.5 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.01 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (AGROVATA, ROTAVATA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17302 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 12.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.6 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, SODIUM ACETATE, PH 5.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.80000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 36.90000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 36.90000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 73.80000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 523 O HOH A 559 0.41 REMARK 500 C3 MAN A 334 C1 MAN A 335 2.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CE LYS A 149 O HOH A 616 3565 0.79 REMARK 500 NZ LYS A 149 O HOH A 616 3565 0.89 REMARK 500 O HOH A 616 CD LYS A 149 2664 1.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL A 4 CA - CB - CG2 ANGL. DEV. = 14.9 DEGREES REMARK 500 PRO A 24 C - N - CA ANGL. DEV. = 10.4 DEGREES REMARK 500 LYS A 28 CD - CE - NZ ANGL. DEV. = 16.3 DEGREES REMARK 500 LEU A 48 CB - CG - CD1 ANGL. DEV. = 11.8 DEGREES REMARK 500 SER A 63 N - CA - CB ANGL. DEV. = 9.7 DEGREES REMARK 500 SER A 79 C - N - CA ANGL. DEV. = 16.2 DEGREES REMARK 500 ASP A 87 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP A 93 CB - CG - OD1 ANGL. DEV. = -10.4 DEGREES REMARK 500 LEU A 94 CB - CG - CD1 ANGL. DEV. = -11.6 DEGREES REMARK 500 GLU A 103 CA - CB - CG ANGL. DEV. = 13.7 DEGREES REMARK 500 LYS A 116 CD - CE - NZ ANGL. DEV. = 15.5 DEGREES REMARK 500 ILE A 128 CB - CG1 - CD1 ANGL. DEV. = -20.4 DEGREES REMARK 500 PHE A 153 CG - CD2 - CE2 ANGL. DEV. = -9.0 DEGREES REMARK 500 PHE A 153 CZ - CE2 - CD2 ANGL. DEV. = 10.5 DEGREES REMARK 500 LEU A 155 CA - CB - CG ANGL. DEV. = 14.6 DEGREES REMARK 500 LEU A 182 CB - CG - CD2 ANGL. DEV. = 11.3 DEGREES REMARK 500 ARG A 186 CA - CB - CG ANGL. DEV. = 18.4 DEGREES REMARK 500 LEU A 199 CB - CG - CD1 ANGL. DEV. = -10.4 DEGREES REMARK 500 ASP A 201 C - N - CA ANGL. DEV. = 15.6 DEGREES REMARK 500 TRP A 241 CA - CB - CG ANGL. DEV. = 35.6 DEGREES REMARK 500 VAL A 278 CA - CB - CG2 ANGL. DEV. = 10.5 DEGREES REMARK 500 LEU A 298 CA - CB - CG ANGL. DEV. = 14.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 66 151.56 -48.03 REMARK 500 ASN A 67 -55.88 -145.34 REMARK 500 ASP A 87 -174.37 176.40 REMARK 500 SER A 159 -73.01 -76.24 REMARK 500 THR A 159C -66.00 -163.10 REMARK 500 GLU A 164 118.30 -166.12 REMARK 500 ALA A 188 -67.35 -138.36 REMARK 500 LEU A 220 -162.03 -106.42 REMARK 500 LYS A 239 89.87 -66.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 SER A 63 -0.7 L D EXPECTING SP3 REMARK 500 PHE A 112 5.2 L L EXPECTING SP3 REMARK 500 GLU A 160 9.5 L L EXPECTING SP3 REMARK 500 ASN A 161 24.0 L L OUTSIDE RANGE REMARK 500 TRP A 241 20.3 L L OUTSIDE RANGE REMARK 500 ILE A 269 25.0 L L OUTSIDE RANGE REMARK 500 TYR A 274 24.2 L L OUTSIDE RANGE REMARK 500 VAL A 278 19.0 L L OUTSIDE RANGE REMARK 500 LEU A 306 23.1 L L OUTSIDE RANGE REMARK 500 ALA A 323 24.7 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL

REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 538 DISTANCE = 5.44 ANGSTROMS REMARK 525 HOH A 610 DISTANCE = 5.43 ANGSTROMS REMARK 525 HOH A 675 DISTANCE = 5.44 ANGSTROMS REMARK 525 HOH A 700 DISTANCE = 5.73 ANGSTROMS REMARK 525 HOH A 701 DISTANCE = 5.97 ANGSTROMS REMARK 525 HOH A 702 DISTANCE = 6.16 ANGSTROMS REMARK 525 HOH A 706 DISTANCE = 7.32 ANGSTROMS REMARK 525 HOH A 708 DISTANCE = 5.22 ANGSTROMS REMARK 525 HOH A 709 DISTANCE = 8.58 ANGSTROMS

REMARK 600 REMARK 600 HETEROGEN REMARK 600 CYCLIC PEPTIDO-MIMETIC STATIN INHIBITOR PD-129,541 WITH KI IN REMARK 600 NANOMOLAR RANGE. THE AUTHORS CALL THE INHIBITOR CYCLIC STATINE REMARK 600 INHIBITOR PD-129,541, BNMA(BIS-[(1-NAPHTHYL)METHYL]ACETIC ACID)-GLU REMARK 600 -STATINE-LEU-AMPMA(META-DI(AMINOMETHYL)BENZENE)

REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: N-[(5S,9S,10S,13S)-9-HYDROXY-5,10-BIS(2- REMARK 630 METHYLPROPYL)-4,7,12,16-TETRAOXO-3,6,11,17-TETRAAZABICYCLO[17.3.1] REMARK 630 TRICOSA-1(23),19,21-TRIEN-13-YL]-3-(NAPHTHALEN-1-YL)-2-(NAPHTHALEN REMARK 630 -1-YLMETHYL)PROPANAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0GM A 338 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: BNA GLU STA LEU TRJ REMARK 630 DETAILS: NULL

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 332 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 333 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MAN A 334 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MAN A 335 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BMA A 336 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDG A 337 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0GM A 338

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2JXR RELATED DB: PDB REMARK 900 RELATED ID: 1DPJ RELATED DB: PDB REMARK 900 RELATED ID: 1FQ4 RELATED DB: PDB REMARK 900 YEAST SACCHAROPEPSIN COMPLEXED WITH CP-108,420. REMARK 900 RELATED ID: 1FQ6 RELATED DB: PDB REMARK 900 YEAST SACCHAROPEPSIN COMPLEXED WITH PD-133,450. REMARK 900 RELATED ID: 1FQ7 RELATED DB: PDB REMARK 900 YEAST SACCHAROPEPSIN COMPLEXED WITH CP-72,647. REMARK 900 RELATED ID: 1FQ8 RELATED DB: PDB REMARK 900 YEAST SACCHAROPEPSIN COMPLEXED WITH CP-81,198.

DBREF 1FQ5 A 0 326 UNP P07267 CARP_YEAST 77 405

SEQADV 1FQ5 ILE A 315 UNP P07267 LEU 394 CONFLICT

SEQRES 1 A 329 GLY GLY HIS ASP VAL PRO LEU THR ASN TYR LEU ASN ALA SEQRES 2 A 329 GLN TYR TYR THR ASP ILE THR LEU GLY THR PRO PRO GLN SEQRES 3 A 329 ASN PHE LYS VAL ILE LEU ASP THR GLY SER SER ASN LEU SEQRES 4 A 329 TRP VAL PRO SER ASN GLU CYS GLY SER LEU ALA CYS PHE SEQRES 5 A 329 LEU HIS SER LYS TYR ASP HIS GLU ALA SER SER SER TYR SEQRES 6 A 329 LYS ALA ASN GLY THR GLU PHE ALA ILE GLN TYR GLY THR SEQRES 7 A 329 GLY SER LEU GLU GLY TYR ILE SER GLN ASP THR LEU SER SEQRES 8 A 329 ILE GLY ASP LEU THR ILE PRO LYS GLN ASP PHE ALA GLU SEQRES 9 A 329 ALA THR SER GLU PRO GLY LEU THR PHE ALA PHE GLY LYS SEQRES 10 A 329 PHE ASP GLY ILE LEU GLY LEU GLY TYR ASP THR ILE SER SEQRES 11 A 329 VAL ASP LYS VAL VAL PRO PRO PHE TYR ASN ALA ILE GLN SEQRES 12 A 329 GLN ASP LEU LEU ASP GLU LYS ARG PHE ALA PHE TYR LEU SEQRES 13 A 329 GLY ASP THR SER LYS ASP THR GLU ASN GLY GLY GLU ALA SEQRES 14 A 329 THR PHE GLY GLY ILE ASP GLU SER LYS PHE LYS GLY ASP SEQRES 15 A 329 ILE THR TRP LEU PRO VAL ARG ARG LYS ALA TYR TRP GLU SEQRES 16 A 329 VAL LYS PHE GLU GLY ILE GLY LEU GLY ASP GLU TYR ALA SEQRES 17 A 329 GLU LEU GLU SER HIS GLY ALA ALA ILE ASP THR GLY THR SEQRES 18 A 329 SER LEU ILE THR LEU PRO SER GLY LEU ALA GLU MET ILE SEQRES 19 A 329 ASN ALA GLU ILE GLY ALA LYS LYS GLY TRP THR GLY GLN SEQRES 20 A 329 TYR THR LEU ASP CYS ASN THR ARG ASP ASN LEU PRO ASP SEQRES 21 A 329 LEU ILE PHE ASN PHE ASN GLY TYR ASN PHE THR ILE GLY SEQRES 22 A 329 PRO TYR ASP TYR THR LEU GLU VAL SER GLY SER CYS ILE SEQRES 23 A 329 SER ALA ILE THR PRO MET ASP PHE PRO GLU PRO VAL GLY SEQRES 24 A 329 PRO LEU ALA ILE VAL GLY ASP ALA PHE LEU ARG LYS TYR SEQRES 25 A 329 TYR SER ILE TYR ASP ILE GLY ASN ASN ALA VAL GLY LEU SEQRES 26 A 329 ALA LYS ALA ILE

MODRES 1FQ5 ASN A 266 ASN GLYCOSYLATION SITE MODRES 1FQ5 ASN A 67 ASN GLYCOSYLATION SITE

HET NAG A 332 14 HET NAG A 333 14 HET MAN A 334 11 HET MAN A 335 11 HET BMA A 336 11 HET NDG A 337 14 HET 0GM A 338 62

HETNAM NAG N-ACETYL-D-GLUCOSAMINE HETNAM MAN ALPHA-D-MANNOSE HETNAM BMA BETA-D-MANNOSE HETNAM NDG 2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE HETNAM 0GM N-[(5S,9S,10S,13S)-9-HYDROXY-5,10-BIS(2-METHYLPROPYL)- HETNAM 2 0GM 4,7,12,16-TETRAOXO-3,6,11,17- HETNAM 3 0GM TETRAAZABICYCLO[17.3.1]TRICOSA-1(23),19,21-TRIEN-13- HETNAM 4 0GM YL]-3-(NAPHTHALEN-1-YL)-2-(NAPHTHALEN-1-YLMETHYL) HETNAM 5 0GM PROPANAMIDE

HETSYN 0GM CP-129,541

FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 2 MAN 2(C6 H12 O6) FORMUL 2 BMA C6 H12 O6 FORMUL 3 NDG C8 H15 N O6 FORMUL 4 0GM C51 H61 N5 O6 FORMUL 5 HOH *105(H2 O)

HELIX 1 1 SER A 47 HIS A 53 1 7 HELIX 2 2 LEU A 110 GLY A 115 1 6 HELIX 3 3 TYR A 125 SER A 129 5 5 HELIX 4 4 SER A 129 VAL A 133 5 5 HELIX 5 5 PRO A 135 GLN A 143 1 9 HELIX 6 6 ASP A 171 SER A 173 5 3 HELIX 7 7 PRO A 224 GLY A 236 1 13 HELIX 8 8 ASP A 248 LEU A 255 5 8 HELIX 9 9 GLY A 302 ARG A 307 1 6

SHEET 1 A 6 HIS A 2 PRO A 5 0 SHEET 2 A 6 GLY A 163 PHE A 167 -1 N ALA A 165 O VAL A 4 SHEET 3 A 6 ARG A 150 LEU A 155 -1 O ALA A 152 N THR A 166 SHEET 4 A 6 TYR A 309 ASP A 314 -1 O SER A 311 N PHE A 153 SHEET 5 A 6 ALA A 319 ALA A 325 -1 O ALA A 319 N ASP A 314 SHEET 6 A 6 PHE A 175 PRO A 183 -1 N LYS A 176 O LYS A 324 SHEET 1 B 8 LYS A 65 TYR A 75 0 SHEET 2 B 8 GLY A 78 GLN A 86 -1 O GLY A 78 N TYR A 75 SHEET 3 B 8 PHE A 101 SER A 106 -1 N PHE A 101 O SER A 85 SHEET 4 B 8 LEU A 38 PRO A 41 1 O LEU A 38 N ALA A 102 SHEET 5 B 8 GLY A 119 GLY A 122 -1 O ILE A 120 N TRP A 39 SHEET 6 B 8 GLN A 25 ASP A 32 1 O LYS A 28 N GLY A 119 SHEET 7 B 8 GLN A 13 LEU A 20 -1 O TYR A 14 N LEU A 31 SHEET 8 B 8 THR A 7 TYR A 9 -1 N THR A 7 O TYR A 15 SHEET 1 C 9 LYS A 65 TYR A 75 0 SHEET 2 C 9 GLY A 78 GLN A 86 -1 O GLY A 78 N TYR A 75 SHEET 3 C 9 PHE A 101 SER A 106 -1 N PHE A 101 O SER A 85 SHEET 4 C 9 LEU A 38 PRO A 41 1 O LEU A 38 N ALA A 102 SHEET 5 C 9 GLY A 119 GLY A 122 -1 O ILE A 120 N TRP A 39 SHEET 6 C 9 GLN A 25 ASP A 32 1 O LYS A 28 N GLY A 119 SHEET 7 C 9 GLN A 13 LEU A 20 -1 O TYR A 14 N LEU A 31 SHEET 8 C 9 LEU A 89 ILE A 91 -1 O SER A 90 N THR A 19 SHEET 9 C 9 LEU A 94 ILE A 96 -1 O LEU A 94 N ILE A 91 SHEET 1 D 4 TYR A 265 ILE A 269 0 SHEET 2 D 4 LEU A 258 PHE A 262 -1 N LEU A 258 O ILE A 269 SHEET 3 D 4 GLU A 191 LEU A 199 -1 N GLU A 195 O ASN A 261 SHEET 4 D 4 GLU A 202 GLU A 205 -1 O GLU A 202 N LEU A 199 SHEET 1 E 7 TYR A 265 ILE A 269 0 SHEET 2 E 7 LEU A 258 PHE A 262 -1 N LEU A 258 O ILE A 269 SHEET 3 E 7 GLU A 191 LEU A 199 -1 N GLU A 195 O ASN A 261 SHEET 4 E 7 GLY A 210 ILE A 214 -1 O ALA A 212 N VAL A 192 SHEET 5 E 7 LEU A 298 VAL A 301 1 N ALA A 299 O GLY A 210 SHEET 6 E 7 ILE A 221 LEU A 223 -1 N THR A 222 O ILE A 300 SHEET 7 E 7 ILE A 286 PRO A 288 1 N THR A 287 O ILE A 221 SHEET 1 F 4 LYS A 238 LYS A 239 0 SHEET 2 F 4 TYR A 245 LEU A 247 -1 O THR A 246 N LYS A 238 SHEET 3 F 4 CYS A 282 SER A 284 -1 O CYS A 282 N LEU A 247 SHEET 4 F 4 THR A 275 GLU A 277 -1 O LEU A 276 N ILE A 283

SSBOND 1 CYS A 45 CYS A 50 1555 1555 1.99 SSBOND 2 CYS A 249 CYS A 282 1555 1555 2.03

LINK ND2 ASN A 266 C1 NDG A 337 1555 1555 1.46 LINK C1 NAG A 332 ND2 ASN A 67 1555 1555 1.47 LINK O4 NAG A 332 C1 NAG A 333 1555 1555 1.45 LINK C1 MAN A 334 O4 NAG A 333 1555 1555 1.43 LINK C1 MAN A 335 O3 MAN A 334 1555 1555 1.45 LINK O2 MAN A 335 C1 BMA A 336 1555 1555 1.49

CISPEP 1 THR A 22 PRO A 23 0 -0.44 CISPEP 2 GLU A 293 PRO A 294 0 4.23 CISPEP 3 GLY A 296 PRO A 297 0 -1.62

SITE 1 AC1 6 ASN A 67 ASP A 100 VAL A 133 NAG A 333 SITE 2 AC1 6 HOH A 524 HOH A 547 SITE 1 AC2 4 ASP A 131 LYS A 132 NAG A 332 MAN A 334 SITE 1 AC3 3 NAG A 333 MAN A 335 BMA A 336 SITE 1 AC4 5 ASP A 126 TYR A 138 GLN A 142 MAN A 334 SITE 2 AC4 5 BMA A 336 SITE 1 AC5 3 MAN A 334 MAN A 335 HOH A 657 SITE 1 AC6 3 ILE A 259 GLY A 264 ASN A 266 SITE 1 AC7 19 ALA A 12 GLN A 13 ASP A 32 GLY A 34 SITE 2 AC7 19 ILE A 73 GLN A 74 TYR A 75 GLY A 76 SITE 3 AC7 19 THR A 77 THR A 111 GLY A 115 ILE A 128 SITE 4 AC7 19 TYR A 189 ASP A 215 GLY A 217 THR A 218 SITE 5 AC7 19 SER A 219 PHE A 291 ILE A 300

CRYST1 87.300 87.300 110.700 90.00 90.00 120.00 P 32 2 1 6

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.011455 0.006613 0.000000 0.00000

SCALE2 0.000000 0.013227 0.000000 0.00000

SCALE3 0.000000 0.000000 0.009033 0.00000